Fig. 9From: The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristoneMifepristone inhibits the adhesion of all five HGSOC cell lines to an organotypic model, composed of fibroblasts embedded in collagen I topped with a monolayer of LP9 cells. HGSOC cells were treated with 20 µM of MF for 72 h prior to plating. Data shown represents the mean ± s.e.m. For panels A[i–iii] and B[i, ii], **P < 0.01 and ***P < 0.001 compared to Vehicle. Vehicle (closed bars), MF (open bars). Statistical analysis was done using two-way ANOVA followed by Bonferroni’s testBack to article page